Dr Naveraj Gill (Strategic Alliance Director)
- MBI® and VISION Leadership Industrial Training Programme Director
- Chair of Industrial Training Advisory Board (ITAB)
- Deputy Head of Department (Enterprise)
Dr Naveraj Gill is the Strategic Alliance Director for the Biochemical Engineering Department at UCL London. Her role is to support the department in forging new links with companies and to foster existing relationships, creating a platform for knowledge transfer and collaboration. She also manages the MBI® industrial training programme which has trained over 1,300 individuals from 300 international companies and is the business lead for the VISION Leadership Programme for the bio-industry. She is a member of the Faculty of Engineering Science Enterprise Impact Team and contributes to the Faculty’s wider industrial strategy. She joined the Department after leading a business development role at GE Healthcare for upstream technologies covering UK and Ireland. Key responsibilities included consulting on client process development strategies, designing in single-use technologies, devising strategies for growing the upstream business, consulting on new product developments and managing new product launches. In 2013 she received GE Healthcare Life Sciences Excellence award for exceptional performance and initiative for creating and driving new projects to promote GE technologies to a wider audience. Prior to her position at GE, she held lead postdoctoral role working on a large Technology Strategy Board (TSB) grant in collaboration with the Public Health England (PHE) and Syntaxin (now Ipsen). Her research focused on the integration of microscale technology for the rapid development of bioprocesses and design for manufacture and also worked as part of the Innovative Manufacturing Research Centre (IMRC) in Bioprocessing funded by Government and Industry. Her research degree was at UCL in collaboration with Hazard Evaluation Laboratories (HEL Ltd.) The project was based on the design and characterisation of automated miniature bioreactor systems.